GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (XCNQ:IMCC) » Definitions » Other Operating Expense

IM Cannabis (XCNQ:IMCC) Other Operating Expense : C$5.41 Mil (TTM As of Mar. 2025)


View and export this data going back to 1980. Start your Free Trial

What is IM Cannabis Other Operating Expense?

IM Cannabis's Other Operating Expense for the three months ended in Mar. 2025 was C$0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was C$5.41 Mil.

IM Cannabis's quarterly Other Operating Expense increased from Sep. 2024 (C$0.00 Mil) to Dec. 2024 (C$5.41 Mil) but then declined from Dec. 2024 (C$5.41 Mil) to Mar. 2025 (C$0.00 Mil).

IM Cannabis's annual Other Operating Expense increased from Dec. 2022 (C$2.76 Mil) to Dec. 2023 (C$2.99 Mil) and increased from Dec. 2023 (C$2.99 Mil) to Dec. 2024 (C$5.41 Mil).


IM Cannabis Other Operating Expense Historical Data

The historical data trend for IM Cannabis's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis Other Operating Expense Chart

IM Cannabis Annual Data
Trend Apr14 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.14 1.28 2.76 2.99 5.41

IM Cannabis Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 - - 5.41 -

IM Cannabis Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$5.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IM Cannabis Other Operating Expense Related Terms

Thank you for viewing the detailed overview of IM Cannabis's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


IM Cannabis Business Description

Traded in Other Exchanges
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Executives
Oren Shuster Director, Senior Officer
Marc Lustig Director, Senior Officer
Karl Grywacheski Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Rafael Gabay 10% Security Holder